Flu may boost Alzheimer’s risk, research suggests

News from the web:

When we come down with the flu, we might think the worst is over after a week of a sore throat and body aches. But such viral infections may have lasting, unseen effects on the brain, emerging research suggests.

Viruses such as influenza and herpes may leave brain cells vulnerable to degeneration later in life, and increase the risk of developing diseases such as Alzheimer’s and Parkinson’s, research suggests. That’s because these the viruses can enter the brain and trigger an immune response — inflammation — which can damage brain cells.

Viruses and other sources of inflammation “may be initiating factors in some of the most common neurological diseases,” said Dr. Ole Isacson, professor of neurology at Harvard Medical School, who discussed the topic in an article published today (Feb. 15) in the journal Science Translational Medicine.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Alzheimer’s: Trouble sleeping could affect memory later on, study finds

News from the web:

People who have trouble sleeping may be at higher risk of developing memory problems, new research shows.

People who woke frequently in the night had a higher risk of developing Alzheimer’s disease, according to work to be presented at the American Academy of Neurology meeting in New Orleans in April.

Other research has shown a link between impaired sleep and multiple-personality disorder, as well as other forms of dissociation.

And research in mice has shown that disrupted sleep can actually cause an increase in the buildup of amyloid plaque in the brain — buildup that happens years before any outward symptoms of Alzheimer’s occur.

To see whether disrupted sleep affected humans, the researchers took 100 patients, half of whom had a family history of Alzheimer’s, and monitored their sleep patterns for 14 days. They found that even though participants spent about eight hours in bed, on average, they spent only about 6.5 hours sleeping, because they woke up repeatedly during the night.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Alzheimer’s path found by Columbia researchers

News from the web:

Columbia University researchers have made a surprising discovery about how Alzheimer’s disease appears to spread in the brain, a finding that could one day lead to early treatment for the memory-robbing disease.

The researcher’s findings – published last week in the journal PLoS One – answered a question that had stumped scientists for 25 years: does Alzheimer’s pop up independently in different parts of the brain or does it spread in a predictable pattern from one specific place in the brain to another.

Read all about it HERE

Hope For Early Alzheimer’s Test In Spinal Fluid

News from the web:

New research led by Nottingham University in the UK suggests abnormal levels of seven proteins in spinal fluid could be markers for the early stages of Alzheimer’s disease, raising hopes of a test for a disease that is difficult to diagnose at the beginning. The researchers write about their findings in the Journal of Alzheimer’s Disease.

Study co-author Dr Kevin Morgan, professor of Human Genomics and Molecular Genetics at Nottingham, told the press on Tuesday that the findings are “a new lead for improving early diagnosis of Alzheimer’s disease”.

An early diagnosis of Alzheimer’s disease would help people prepare for the future and also enable them to be involved in clinical trials at a much earlier stage of the disease, when treatments are more likely to show positive results, he added.

Read all about it HERE

Alzheimer’s Families Clamor for Drug

News from the web:

In the wake of research suggesting a skin-cancer drug may have benefits in treating Alzheimer’s disease, physicians and advocacy groups are getting a flurry of calls from patients seeking to use the drug off-label.

The clamor underscores how urgently patients want solutions to the rising tide of Alzheimer’s. But experts caution that more research is needed to determine whether the drug, bexarotene, is effective in humans at all, not to mention what the dosage should be.

The study, published Thursday in the journal Science, was conducted in mice, and the road to an effective Alzheimer’s treatment is littered with failures that looked promising early on in animals.

Read all about it HERE

New Attack on Alzheimer’s

News from the web:

A cancer drug quickly and dramatically improved brain function and social ability and restored the sense of smell in mice bred with a form of Alzheimer’s disease, suggesting a new way to tackle the illness in people.

Alzheimer’s is associated with the accumulation of protein fragments called amyloid-beta in the brain. The new research found that an existing skin-cancer drug called bexarotene cleared the protein in the brains of stricken mice within days. The study was published Thursday in the journal Science.

Read all about it HERE